|
US3300077A
(en)
|
1965-02-18 |
1967-01-24 |
Clinch Tite Corp |
Pallet enclosure
|
|
EP0486526B2
(en)
|
1989-08-07 |
2001-03-07 |
Peptech Limited |
Tumour necrosis factor binding ligands
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
AU664561B2
(en)
|
1991-06-21 |
1995-11-23 |
University Of Cincinnati, The |
Orally administrable therapeutic proteins and method of making
|
|
DE69334275D1
(de)
|
1992-08-21 |
2009-05-20 |
Univ Bruxelles |
Immunoglobuline ohne Leichtkette
|
|
WO1994025591A1
(en)
|
1993-04-29 |
1994-11-10 |
Unilever N.V. |
PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
|
|
US5512459A
(en)
*
|
1993-07-20 |
1996-04-30 |
Bionebraska, Inc. |
Enzymatic method for modification or recombinant polypeptides
|
|
US5780028A
(en)
|
1993-09-20 |
1998-07-14 |
Anadis Ltd. |
Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
|
|
EP0739981A1
(en)
*
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
DK1027439T3
(da)
|
1997-10-27 |
2010-05-10 |
Bac Ip Bv |
Multivalente antigenbindende proteiner
|
|
EP0954978B1
(en)
|
1998-03-12 |
2011-11-30 |
VHsquared Limited |
New products comprising inactivated yeasts or moulds provided with active antibodies
|
|
ES2299244T3
(es)
*
|
1998-05-13 |
2008-05-16 |
Domantis Limited |
Sistema de exposicion de fagos para la seleccion de proteinas correctamente plegadas.
|
|
AUPP702498A0
(en)
|
1998-11-09 |
1998-12-03 |
Silverbrook Research Pty Ltd |
Image creation method and apparatus (ART77)
|
|
GB9909301D0
(en)
|
1999-04-22 |
1999-06-16 |
Kci Medical Ltd |
Wound treatment apparatus employing reduced pressure
|
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
PL204737B1
(pl)
|
2000-12-13 |
2010-02-26 |
Unilever Nv |
Sposób wytwarzania heterologicznego białka przez grzyby
|
|
IL159177A0
(en)
|
2001-06-20 |
2004-06-01 |
Prochon Biotech Ltd |
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
|
|
TWI327597B
(en)
|
2001-08-01 |
2010-07-21 |
Centocor Inc |
Anti-tnf antibodies, compositions, methods and uses
|
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
US9770517B2
(en)
*
|
2002-03-01 |
2017-09-26 |
Immunomedics, Inc. |
Anti-Trop-2 antibody-drug conjugates and uses thereof
|
|
US20040131614A1
(en)
|
2002-07-19 |
2004-07-08 |
Abbott Biotechnology Ltd. |
Treatment of pulmonary disorders using TNFalpha inhibitor
|
|
MY150740A
(en)
|
2002-10-24 |
2014-02-28 |
Abbvie Biotechnology Ltd |
Low dose methods for treating disorders in which tnf? activity is detrimental
|
|
EP1558645B1
(en)
|
2002-11-08 |
2011-07-27 |
Ablynx N.V. |
Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
|
|
NZ540194A
(en)
|
2002-11-08 |
2008-07-31 |
Ablynx Nv |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
US20060034833A1
(en)
|
2002-11-08 |
2006-02-16 |
Els Beirnaert |
Single domain antibodies directed against interferron-gamma and uses therefor
|
|
CA2817265A1
(en)
|
2003-04-11 |
2004-10-28 |
Medimmune, Llc |
Recombinant il-9 antibodies and uses thereof
|
|
US7758859B2
(en)
|
2003-08-01 |
2010-07-20 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
US8007827B2
(en)
|
2004-04-02 |
2011-08-30 |
Impax Laboratories, Inc. |
Pharmaceutical dosage forms having immediate release and/or controlled release properties
|
|
TWI439284B
(zh)
|
2004-04-09 |
2014-06-01 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
ATE474118T1
(de)
|
2004-07-14 |
2010-07-15 |
Blum Gmbh Julius |
Stellmechanismus für einen schwenkbar gelagerten stellarm
|
|
MX2007006086A
(es)
|
2004-11-25 |
2007-07-11 |
Unilever Nv |
Anticuerpos de cadena pesada y de dominio.
|
|
CA2592015A1
(en)
|
2004-12-27 |
2006-07-06 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally deliverable and anti-toxin antibodies and methods for making and using them
|
|
US7234616B2
(en)
|
2004-12-27 |
2007-06-26 |
Bel-Art Products, Inc. |
Friction arrangement for hosiery donning aid
|
|
AU2006249144B2
(en)
|
2005-05-18 |
2011-11-17 |
Ablynx Nv |
Improved NanobodiesTM against Tumor Necrosis Factor-alpha
|
|
JP2008543839A
(ja)
|
2005-06-14 |
2008-12-04 |
アムジェン インコーポレーテッド |
自己緩衝タンパク質製剤
|
|
US20070042399A1
(en)
*
|
2005-06-23 |
2007-02-22 |
Imperial College Innovations Limited |
Biological materials and uses thereof
|
|
CA2613818C
(en)
|
2005-06-30 |
2013-08-27 |
Centocor, Inc. |
Anti-il-23 antibodies, compositions, methods and uses
|
|
JP5049973B2
(ja)
|
2005-08-30 |
2012-10-17 |
アクトジェニックス・エヌブイ |
慢性全腸炎の治療のための、抗−ＴＮＦα産生乳酸菌
|
|
ME02705B
(me)
|
2005-08-31 |
2017-10-20 |
Merck Sharp & Dohme |
Inženjerisana anti-il-23 antitela
|
|
WO2007048022A2
(en)
*
|
2005-10-21 |
2007-04-26 |
Alexion Pharmaceuticals, Inc. |
Antibody-polypeptide fusion proteins and methods for producing and using same
|
|
US20090286962A1
(en)
|
2005-12-20 |
2009-11-19 |
Woolven Benjamin P |
Chimeric antibodies with part new world primate binding regions
|
|
WO2007104529A2
(en)
|
2006-03-13 |
2007-09-20 |
Ablynx N.V. |
Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
|
|
US20080026820A1
(en)
|
2006-07-05 |
2008-01-31 |
Aruze Gaming America, Inc. |
Slot machine and playing method thereof
|
|
US20080031770A1
(en)
|
2006-08-02 |
2008-02-07 |
Douglas Heselton |
Apparatus and method for using ozone as a disinfectant
|
|
JP2010500876A
(ja)
|
2006-08-18 |
2010-01-14 |
アブリンクス エン．ヴェー． |
Ｉｌ−６媒介性シグナル伝達に関連する疾患及び障害の治療のための、ｉｌ−６ｒに指向性を有するアミノ酸配列及びこれを含むポリペプチド
|
|
EP2081555A2
(en)
|
2006-09-12 |
2009-07-29 |
Cosmo Technologies Ltd. |
Pharmaceutical compositions for the oral or rectal administration of protein substances
|
|
WO2008039761A2
(en)
|
2006-09-25 |
2008-04-03 |
Medimmune, Llc. |
Stabilized antibody formulations and uses thereof
|
|
EP2071927A2
(en)
*
|
2006-09-28 |
2009-06-24 |
Illumina, Inc. |
Compositions and methods for nucleotide sequencing
|
|
WO2008049897A1
(en)
|
2006-10-27 |
2008-05-02 |
Ablynx N.V. |
Intranasal delivery of polypeptides and proteins
|
|
TW200823720A
(en)
|
2006-11-27 |
2008-06-01 |
Asustek Comp Inc |
Portable computer
|
|
US20080145420A1
(en)
|
2006-12-13 |
2008-06-19 |
Simon Michael R |
HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
|
|
WO2008075356A2
(en)
|
2006-12-19 |
2008-06-26 |
Shay Bushinsky |
Interactive broadcast system and method
|
|
US9156914B2
(en)
|
2006-12-19 |
2015-10-13 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
|
TWI317699B
(en)
|
2006-12-25 |
2009-12-01 |
Ind Tech Res Inst |
Device and method for removing residues
|
|
US7459949B2
(en)
|
2007-01-30 |
2008-12-02 |
Mosaid Technologies Incorporated |
Phase detector circuit and method therefor
|
|
US20160031971A9
(en)
|
2007-02-20 |
2016-02-04 |
Tufts University |
Methods and compositions with a recombinant neutralizing binding protein for treating toxin exposure
|
|
PT2079445E
(pt)
|
2007-02-20 |
2016-02-29 |
Allergan Pharmaceuticals Internat Ltd |
Composições de enzimas digestivas estáveis
|
|
CN101663319A
(zh)
|
2007-02-21 |
2010-03-03 |
埃博灵克斯股份有限公司 |
针对血管内皮生长因子的氨基酸序列和包括其的多肽用于治疗特征在于过量和/或病理性血管发生或新血管形成的病症和疾病
|
|
EP2061440A2
(en)
|
2007-04-04 |
2009-05-27 |
Sigmoid Pharma Limited |
A pharmaceutical composition of tacrolimus
|
|
US7807168B2
(en)
|
2007-04-10 |
2010-10-05 |
Vaccinex, Inc. |
Selection of human TNFα specific antibodies
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
WO2008144753A2
(en)
|
2007-05-21 |
2008-11-27 |
Alder Biopharmaceuticals, Inc. |
Antibodies to tnf alpha and use thereof
|
|
GB0724331D0
(en)
|
2007-12-13 |
2008-01-23 |
Domantis Ltd |
Compositions for pulmonary delivery
|
|
CA2696263C
(en)
*
|
2007-08-15 |
2017-06-13 |
Bing Liu |
Monospecific and multispecific antibodies and method of use
|
|
TWM333751U
(en)
|
2007-09-07 |
2008-06-01 |
Jarllytec Co Ltd |
Supporting-type pivot structure
|
|
US20100239682A1
(en)
|
2007-09-17 |
2010-09-23 |
Antoine Andremont |
Colonic delivery of antimicrobial agents
|
|
WO2009046168A1
(en)
|
2007-10-02 |
2009-04-09 |
Avaxia Biologics, Inc. |
Antibody therapy for use in the digestive tract
|
|
DK3354276T3
(da)
|
2007-11-13 |
2020-03-30 |
Meritage Pharma Inc |
Sammensætninger til behandlingen af gastrointestinal inflammation
|
|
CA2706425A1
(en)
|
2007-11-27 |
2009-06-04 |
Ablynx N.V. |
Method for obtaining polypeptide constructs comprising two or more single domain antibodies
|
|
EP2238093A1
(en)
|
2008-02-07 |
2010-10-13 |
Total Petrochemicals Research Feluy |
Dehydration of alcohols in the presence of an inert component
|
|
TW201920257A
(zh)
|
2008-04-11 |
2019-06-01 |
日商中外製藥股份有限公司 |
重複結合複數個抗原的抗原結合分子
|
|
LT2285408T
(lt)
|
2008-06-05 |
2019-01-25 |
Ablynx N.V. |
Aminorūgščių sekos, nukreiptos prieš viruso apvalkalo baltymus, ir tokias sekas turintys polipeptidai, skirti virusinių ligų gydymui
|
|
ES2425977T3
(es)
|
2008-08-14 |
2013-10-18 |
Nippon Paper Chemicals Co., Ltd. |
Composición de resina dispersante, y composición de pintura, composición de tinta, composición adhesiva y composición de imprimación que la contienen
|
|
GB0815264D0
(en)
|
2008-08-21 |
2008-09-24 |
Syntaxin Ltd |
Non-cytotoxic proteins
|
|
CN102215875B
(zh)
*
|
2008-10-16 |
2014-08-06 |
凯瑟琳·科根·法瑞纳斯 |
持续药物递送系统
|
|
PL2346927T3
(pl)
|
2008-10-17 |
2014-12-31 |
Maxbiogas Gmbh |
Sposób fermentacji biomasy zawierającej ligninę wraz z celulozą i/lub hemicelulozą
|
|
RU2481824C2
(ru)
|
2008-10-29 |
2013-05-20 |
Аблинкс Н.В |
Препараты однодоменных антигенсвязывающих молекул
|
|
CN105646643A
(zh)
|
2008-10-29 |
2016-06-08 |
阿布林克斯公司 |
单域抗原结合性分子的纯化方法
|
|
US8697654B2
(en)
*
|
2008-12-18 |
2014-04-15 |
E I Du Pont De Nemours And Company |
Peptide linkers for effective multivalent peptide binding
|
|
WO2010085643A1
(en)
|
2009-01-22 |
2010-07-29 |
University Of Miami |
Targeting il-7 signaling as a therapy for multiple sclerosis and other il-7 signaling dependent disorders
|
|
MX2011010681A
(es)
|
2009-04-10 |
2012-01-20 |
Ablynx Nv |
Secuencias mejoradas de aminoacidos dirigidas contra il-6r y polipeptidos que comprenden el mismo para el tratamiento de enfermedades y trastornos relacionados con il-6r.
|
|
US9056050B2
(en)
|
2009-04-13 |
2015-06-16 |
Curemark Llc |
Enzyme delivery systems and methods of preparation and use
|
|
CN101964403A
(zh)
|
2009-07-23 |
2011-02-02 |
比克国际(天津)有限公司 |
一种电池组的封装方法及电池组
|
|
CN102090373A
(zh)
|
2009-12-11 |
2011-06-15 |
中国医学科学院血液病医院（血液学研究所） |
模拟人克隆氏病的小鼠结肠炎模型及其制备方法和用途
|
|
CL2010000019A1
(es)
|
2010-01-11 |
2010-06-11 |
Univ Chile |
Anticuerpo monoclonal contra el tnf humano y sus fragmentos, secuencias nucleotidicas que lo codifican, vector de expresion y celulas que las contienen, composiciones y kit que comprenden el anticuerpo, uso de los mismos y metodo para su obtencion.
|
|
CA2787070A1
(en)
|
2010-01-28 |
2011-08-04 |
Ian Kirby |
Cd127 binding proteins
|
|
US20130012916A1
(en)
|
2010-02-11 |
2013-01-10 |
Glide Pharmaceutical Technologies Limited |
Delivery of immunoglobulin variable domains and constructs thereof
|
|
AR080291A1
(es)
|
2010-02-24 |
2012-03-28 |
Rinat Neuroscience Corp |
Anticuerpos antagonistas anti receptor de il-7 y procedimientos
|
|
CN105168174B
(zh)
|
2010-03-10 |
2019-01-08 |
拉尼医疗有限公司 |
用于利用可吞咽式药剂递送装置递送到肠道内腔中的治疗剂制剂
|
|
WO2011139629A2
(en)
*
|
2010-04-26 |
2011-11-10 |
Biogen Idec Ma Inc. |
Light targeting molecules and uses thereof
|
|
AU2011247612A1
(en)
|
2010-04-30 |
2012-12-06 |
Ablynx Nv |
Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine IL-23
|
|
WO2011135040A1
(en)
*
|
2010-04-30 |
2011-11-03 |
F. Hoffmann-La Roche Ag |
Fluorescent antibody fusion protein, its production and use
|
|
WO2011139269A1
(en)
|
2010-05-04 |
2011-11-10 |
Johnson Controls Technology Company |
Variable speed drive
|
|
AU2011277983C1
(en)
|
2010-07-16 |
2016-09-29 |
Ablynx Nv |
Modified single domain antigen binding molecules and uses thereof
|
|
CA2815888C
(en)
|
2010-10-25 |
2020-06-30 |
National Research Council Of Canada |
Clostridium difficile-specific antibodies and uses thereof
|
|
US9460623B2
(en)
|
2010-11-22 |
2016-10-04 |
International Business Machines Corporation |
Parking management
|
|
AR084210A1
(es)
|
2010-12-08 |
2013-05-02 |
Abbott Lab |
PROTEINAS DE UNION AL TNF-a
|
|
US8566574B2
(en)
|
2010-12-09 |
2013-10-22 |
International Business Machines Corporation |
Secure encrypted boot with simplified firmware update
|
|
US8634563B2
(en)
|
2010-12-17 |
2014-01-21 |
Microsoft Corporation |
Attribute based encryption using lattices
|
|
WO2012130872A1
(en)
|
2011-03-28 |
2012-10-04 |
Ablynx Nv |
Method for producing solid formulations comprising immunoglobulin single variable domains
|
|
MX2013011366A
(es)
|
2011-03-30 |
2014-05-12 |
Chugai Pharmaceutical Co Ltd |
Retencion de las moleculas de union al antigeno en el plasma sanguineo y metodo para modificar la inmunogenicidad.
|
|
AU2012237287B2
(en)
|
2011-03-30 |
2016-09-08 |
Ablynx Nv |
Methods of treating immune disorders with single domain antibodies against TNF-alpha
|
|
US9527925B2
(en)
|
2011-04-01 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to VEGF and ANG2
|
|
AU2012250924B2
(en)
|
2011-05-02 |
2017-05-25 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
|
CA3141978A1
(en)
|
2011-06-23 |
2012-12-27 |
Ablynx Nv |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
MY167125A
(en)
|
2011-08-17 |
2018-08-13 |
Glaxo Group Ltd |
Modified proteins and peptides
|
|
KR20140084201A
(ko)
*
|
2011-10-19 |
2014-07-04 |
알렉시온 파마 홀딩 |
알칼리성 포스파타제 및/또는 나트륨이뇨 펩티드를 포함하는 조성물 및 그의 사용 방법
|
|
EP2583980A1
(en)
|
2011-10-19 |
2013-04-24 |
Effimune |
Antibodies directed against the alpha chain of IL7 receptor - their use for the preparation of drug candidates
|
|
GB2504139B
(en)
|
2012-07-20 |
2014-12-31 |
Argen X Bv |
Antibodies to highly conserved targets produced by the immunisation of Camelidae species
|
|
DE102011121238A1
(de)
|
2011-12-14 |
2013-06-20 |
Universitätsklinikum Hamburg-Eppendorf |
Einzeldomänen-antikörper gegen clostridium difficile toxine
|
|
DE102011121237A1
(de)
|
2011-12-14 |
2013-06-20 |
Universitätsklinikum Hamburg-Eppendorf |
Einzeldomänen-Antikörper gegen Clostridium difficile Toxin CDTa
|
|
CN104169304A
(zh)
|
2011-12-20 |
2014-11-26 |
阿达拉塔合伙有限公司 |
作为pcsk9抑制剂的单域抗体
|
|
US8874636B2
(en)
|
2012-01-03 |
2014-10-28 |
Teletech Holdings, Inc. |
Method for providing support services using consumer selected specialist and specialist ratings
|
|
PL2831111T3
(pl)
*
|
2012-03-30 |
2019-09-30 |
Boehringer Ingelheim International Gmbh |
Cząsteczki wiążące Ang2
|
|
SI2849723T1
(sl)
|
2012-05-18 |
2018-09-28 |
Genentech, Inc. |
Formulacije z visoko koncentracijo monoklonskih protiteles
|
|
US9617334B2
(en)
|
2012-06-06 |
2017-04-11 |
Zoetis Services Llc |
Caninized anti-NGF antibodies and methods thereof
|
|
WO2014004746A2
(en)
|
2012-06-26 |
2014-01-03 |
Harvard Bioscience, Inc. |
Methods and compositions for promoting the structural integrity of scaffolds for tissue engineering
|
|
JP2014026709A
(ja)
|
2012-07-30 |
2014-02-06 |
International Business Maschines Corporation |
ライブラリ・ストリング間でのカートリッジの移動方法、システム、及びプログラム
|
|
NZ704771A
(en)
|
2012-08-13 |
2018-02-23 |
Regeneron Pharma |
Anti-pcsk9 antibodies with ph-dependent binding characteristics
|
|
EP2887960A2
(en)
|
2012-08-21 |
2015-07-01 |
Glaxo Group Limited |
Compositions comprising a single variable domain and camostat mesylate (cm)
|
|
MX2015004436A
(es)
|
2012-10-09 |
2015-06-24 |
Biogen Idec Inc |
Tratamientos conjuntos y usos para tratar trastornos desmielinizantes.
|
|
KR101911438B1
(ko)
|
2012-10-31 |
2018-10-24 |
삼성전자주식회사 |
이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법
|
|
US20140186365A1
(en)
*
|
2013-01-03 |
2014-07-03 |
Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center |
Antibodies that specifically bind to serum albumin without interfering with albumin's capability to interact with the fcrn
|
|
SG11201507026WA
(en)
|
2013-02-06 |
2015-10-29 |
Anthrogenesis Corp |
Modified t lymphocytes having improved specificity
|
|
AU2014229282B2
(en)
|
2013-03-15 |
2017-02-02 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Low concentration antibody formulations
|
|
WO2015009996A1
(en)
|
2013-07-19 |
2015-01-22 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating eosinophilic esophagitis
|
|
US20150058173A1
(en)
|
2013-08-20 |
2015-02-26 |
Sears Brands, Llc |
Sales promotion using product comparison
|
|
US20160228371A1
(en)
|
2013-10-18 |
2016-08-11 |
Abbvie Inc. |
Stable solid units and methods of making the same
|
|
CA2924520C
(en)
|
2013-11-01 |
2023-09-26 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
|
|
WO2015100409A2
(en)
|
2013-12-26 |
2015-07-02 |
Tufts University |
Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein
|
|
US10233238B2
(en)
|
2014-03-26 |
2019-03-19 |
Cell Medica Switzerland Ag |
TNF alpha antibody or fragment thereof and methods of use
|
|
WO2015176031A2
(en)
|
2014-05-15 |
2015-11-19 |
Incube Labs, Llc |
Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
|
|
EP2955196A1
(en)
|
2014-06-10 |
2015-12-16 |
Effimune |
Antibodies directed against CD127
|
|
CA2959629C
(en)
|
2014-09-03 |
2023-10-31 |
Boehringer Ingelheim International Gmbh |
Compound targeting il-23a and tnf-alpha and uses thereof
|
|
PL3590962T3
(pl)
|
2014-10-23 |
2022-01-31 |
Singh Molecular Medicine, Llc |
Przeciwciała jednodomenowe przeciwko antygenom wewnątrzkomórkowym
|
|
US20170360929A1
(en)
|
2014-12-23 |
2017-12-21 |
Pfizer Inc. |
Stable aqueous antibody formulation for anti tnf alpha antibodies
|
|
US20170260266A1
(en)
|
2015-03-11 |
2017-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
Tslp binding proteins
|
|
EP3277706A1
(en)
|
2015-03-31 |
2018-02-07 |
VHsquared Limited |
Polypeptide comprising an immunoglobulin chain variable domain which binds to clostridium difficile toxin b
|
|
WO2016156474A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Polypeptide comprising an immunoglobulin chain variable domain which binds to clostridium difficile toxin a
|
|
EP3277719B1
(en)
|
2015-03-31 |
2022-03-16 |
Sorriso Pharmaceuticals, Inc. |
Polypeptides
|
|
AU2016239949A1
(en)
|
2015-03-31 |
2017-09-07 |
Sorriso Pharmaceuticals, Inc. |
Peptide construct having a protease-cleavable linker
|
|
WO2016156468A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Polypeptides
|
|
EP3078675A1
(en)
|
2015-04-10 |
2016-10-12 |
Ares Trading S.A. |
Induction dosing regimen for the treatment of tnf alpha mediated disorders
|
|
GB201510758D0
(en)
|
2015-06-18 |
2015-08-05 |
Ucb Biopharma Sprl |
Novel TNFa structure for use in therapy
|
|
EP3405491A1
(en)
|
2016-01-21 |
2018-11-28 |
VHsquared Limited |
Polypeptides
|
|
EP3435982A1
(en)
|
2016-03-31 |
2019-02-06 |
VHsquared Limited |
Compositions
|
|
WO2018060453A1
(en)
|
2016-09-30 |
2018-04-05 |
Vhsquared Limited |
Compositions
|
|
CN110392695B
(zh)
|
2016-12-09 |
2021-02-02 |
Ose免疫疗法 |
针对cd127的抗体和多肽
|
|
EP3635410A4
(en)
|
2017-06-04 |
2021-03-10 |
Rappaport Family Institute for Research in the Medical Sciences |
PROCEDURE FOR PREDICTING PERSONALIZED RESPONSE TO CANCER TREATMENT USING IMMUNE CHECKPOINT INHIBITORS AND KITS
|
|
AR112341A1
(es)
|
2017-08-02 |
2019-10-16 |
Lilly Co Eli |
ANTICUERPOS BIESPECÍFICOS ANTI-TNF- / ANTI-IL-23 DE IgG
|
|
JP7692844B2
(ja)
*
|
2019-06-21 |
2025-06-16 |
ソリッソ ファーマシューティカルズ，インク． |
ポリペプチド
|
|
US12570736B2
(en)
*
|
2019-06-21 |
2026-03-10 |
Sorriso Pharmaceuticals, Inc. |
Compositions
|
|
CA3144566A1
(en)
*
|
2019-06-21 |
2020-12-24 |
Sorriso Pharmaceuticals, Inc. |
Polypeptides
|